Time-of-drug-addition assay

WT Wen-Fang Tang
HT Hui-Ping Tsai
YC Yu-Hsiu Chang
TC Tein-Yao Chang
CH Chung-Fan Hsieh
CL Chia-Yi Lin
GL Guan-Hua Lin
YC Yu-Li Chen
JJ Jia-Rong Jheng
PL Ping-Cheng Liu
CY Chuen-Mi Yang
YC Yuan-Fan Chin
CC Cheng Cheung Chen
JK Jyh-Hwa Kau
YH Yi-Jen Hung
PH Po-Shiuan Hsieh
JH Jim-Tong Horng
ask Ask a question
Favorite

PLE (1.25 mg/mL) was incubated with Vero E6 cells in six-well plates (1 mL/well) between −3 h post-infection (p.i.) and 0 h p.i., between −1 h p.i. and 0 h p.i., between 0 h p.i. and 24 h p.i., and between −3 h and 24 h p.i. at 37 °C. The virus was absorbed to cells between −1 h p.i. and 0 h p.i. at an MOI of 0.01. Cell lysates from each treatment were harvested at 24 h p.i. for quantitative reverse transcription polymerase chain reaction (qRT-PCR) and Western blot analyses.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A